Inhibition of FASN and SREBP-1c expression has been reported to effectively prevent fatty acid biosynthesis, accelerate fatty acid oxidation to abolish the abnormal accumulation of FFAs, and thereby alleviate obesity and other lipid metabolism diseases [8]. This evidence concerns the gene FASN and obesity disorder.